Serum free prostate specific antigen and prostate specific antigen density measurements for predicting cancer in men with prior negative prostatic biopsies

Journal of Urology

Volumn 158, Issue 6, 1997, Pages 2162-2167

  Catalona, William J ^a,b   Beiser, Julia A ^a   Smith, Deborah S ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Division of Urologic Surgery   (United States)

Author keywords

Biopsy; Prostate specific antigen; Prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; DENSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PREDICTION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER;

EID: 0030772921     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)68187-4     Document Type: Article

References (13)

1. Keetch, D. W., Catalona, W. J. and Smith, D. S.: Serial prostate biopsies in men with persistently elevated serum prostate specific antigen values. J. Urol., 151: 1571, 1994.
2. Stenman, U. H., Hakama, M., Knekt, P., Aromaa, A., Teppo, L. and Leinonen, J.: Serum concentration of prostate specific antigen and its complex with alpha 1-antichymotrypsin before diagnosis of prostate cancer. Lancet, 344: 1594, 1994.
3. Luderer, A. A., Chen, Y. T., Soriano, T. F., Kramp, W. J., Carlosn, G., Cuny, C., Sharp, T., Smith, W., Petteway, J. and Brawer, M. K.: Measurement of the proportion of free to total prostate-specific antigen improves diagnostic performance of prostate-specific antigen in the diagnostic gray zone of total prostate-specific antigen. Urology, 46: 187, 1995.
4. Catalona, W. J., Smith, D. S., Wolfert, R. L., Wang, T. J., Rittenhouse, H. G., Ratliff, T. L. and Nadler, R. B.: Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. J.A.M.A., 274: 1214, 1995.
5. Seaman, E., Katz, A., Cooner, W. C., Whang, I. S., Olsson, C. A., Kistler, S. and Benson, M. C.: An algorithm for prostate cancer detection based upon PSA, TRUS, DRE, PSA density and PSA velocity. J. Urol., part 2, 149: 414A, abstract 805, 1993.
6. Morgan, T. O., McLeod, D. G., Leifer, E. S., Murphy, G. P. and Moul, J. W.: Prospective use of free prostate-specific antigen to avoid repeat prostate biopsies in men with elevated total prostate-specific antigen. Urology, suppl., 48: 76, 1996.
7. Keetch, D. W., McMurty, J. M., Smith, D. S., Andriole, G. L. and Catalona, W. J.: Prostate specific antigen density versus prostate specific antigen slope as predictors of prostate cancer in men with initially negative prostatic biopsies. J. Urol., 156: 428, 1996.
8. Smith, D. S., Bullock, A. D., Catalona, W. J. and Herschman, J. D.: Racial differences in a prostate cancer screening study. J. Urol., 156: 1366, 1996.
9. Catalona, W. J., Smith, D. S., Ratliff, T. L. and Basler, J. W.: Detection of organ-confined cancer is increased through prostate-specific antigen-based screening. J.A.M.A., 270: 948, 1993.
10. Catalona, W. J., Smith, D. S., Ratliff, T. L., Dodds, K. M., Coplen, D. E., Yuan, J. J. J., Petros, J. A. and Andriole, G. L.: Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. New Engl. J. Med., 324: 1156, 1991.
11. Hosmer, D. W., Jr. and Lemeshow, S.: Applied Logistic Regression. New York: John Wiley & Sons, pp. 89-93, 1989.
12. Bazinet, M., Karakiewicz, P. I., Aprikian, A. G., Trudel, C., Péloquin, F., Dessureault, J., Goyal, M., Bégin, L. R. and Elhilali, M. M.: Reassessment of nonplanimetric transrectal ultrasound prostate volume estimates. Urology, 47: 857, 1996.
13. Catalona, W. J., Partin, A. W., Slawin, K. M., Brawer, M. K., Patel, A., Flanigan, R. C., Richie, J. P., deKernion, J. B., Walsh, P. C., Scardino, P. T., Lange, P. H., Herschman, J. D., Subong, E. N. P., Petteway, J. C., Parson, R. E., Loveland, K. G., Gasior, G. H. and Southwick, P. C.: A multicenter clinical trial evaluation of free PSA in the differentiation of prostate cancer from benign disease. J. Urol., part 2, 157: abstract 434, 111, 1997.